Bullboard - Stock Discussion Forum Palisade Bio Inc PALI

Healthcare Biotechnology

Palisade Bio, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal diseases. It is engaged in advancing a PALI-2108 for the treatment of IBD, including UC and CD and are researching PALI-1908. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract. UC primarily affects the colon and the rectum. CD... see more

Add To Watchlist

NDAQ:PALI - Post Discussion

Palisade Bio Inc > Palisade Bio Cleared by Health Canada to Commence Phase 1 Cl

View:

Post by whytestocks on Oct 10, 2024 5:02pm

Palisade Bio Cleared by Health Canada to Commence Phase 1 Cl

NEWS: $PALI Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC)– Company has received a No Objection Letter from Health Canada in response to submission of its Phase 1 Clinical Trial Application (CTA) – The study is a Phase 1 Single Ascending Dose (SAD) /Multiple Ascending Dose (MAD) and food effects (FE) and includes multiple d...PALI - Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC)